Overview

Study to Evaluate the Effect of Co-administered ACT-1014-6470 on the Pharmacokinetics of Omeprazole and Midazolam

Status:
Not yet recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

A study on whether ACT-1014-6470 has an effect on how the body takes up, distributes and gets rid of omeprazole and midazolam in healthy male subjects

Phase:

Phase 1

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.

Treatments:

Midazolam
Omeprazole